ConvaTec Group PLC banner

ConvaTec Group PLC
LSE:CTEC

Watchlist Manager
ConvaTec Group PLC Logo
ConvaTec Group PLC
LSE:CTEC
Watchlist
Price: 220.8 GBX -1.69% Market Closed
Market Cap: £4.3B

ConvaTec Group PLC
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

ConvaTec Group PLC
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
ConvaTec Group PLC
LSE:CTEC
Free Cash Flow
$285m
CAGR 3-Years
28%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Abingdon Health PLC
LSE:ABDX
Free Cash Flow
-£3.5m
CAGR 3-Years
25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Tristel PLC
LSE:TSTL
Free Cash Flow
£9m
CAGR 3-Years
22%
CAGR 5-Years
9%
CAGR 10-Years
13%
Inspecs Group PLC
LSE:SPEC
Free Cash Flow
£4.3m
CAGR 3-Years
-30%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Advanced Medical Solutions Group PLC
LSE:AMS
Free Cash Flow
£20m
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
1%
Rua Life Sciences PLC
LSE:RUA
Free Cash Flow
-£354k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

ConvaTec Group PLC
Glance View

Market Cap
4.3B GBX
Industry
Health Care

ConvaTec Group PLC is a notable player in the realm of medical products and technologies, deftly weaving its narrative within the healthcare industry. Founded in 1978, the company has steadily established itself through strategic expansion and innovation, focusing on improving the lives of patients and enhancing healthcare delivery. The company's core business revolves around four main product categories: Advanced Wound Care, Ostomy Care, Continence and Critical Care, and Infusion Care. Each of these sectors is backed by a robust commitment to research and development, allowing ConvaTec to deliver specialized products that cater to both specific patient needs and broader healthcare system demands. ConvaTec's financial model centers around providing essential, high-quality medical solutions that ultimately support improved patient outcomes. The company garners revenue by partnering with hospitals, healthcare providers, and direct consumer channels, ensuring its products reach where they are most needed. With a global footprint spanning multiple continents, ConvaTec not only distributes its products widely but also adapts its strategy to meet the nuanced requirements of diverse markets. By aligning itself closely with caregivers and leveraging cutting-edge technology, the company maintains a sustainable economic engine through both recurring sales from consumables and long-term relationships with its institutional clients.

CTEC Intrinsic Value
200.95 GBX
Overvaluation 9%
Intrinsic Value
Price GBX220.8

See Also

What is ConvaTec Group PLC's Free Cash Flow?
Free Cash Flow
285m USD

Based on the financial report for Dec 31, 2025, ConvaTec Group PLC's Free Cash Flow amounts to 285m USD.

What is ConvaTec Group PLC's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-2%

Over the last year, the Free Cash Flow growth was 4%. The average annual Free Cash Flow growth rates for ConvaTec Group PLC have been 28% over the past three years , -2% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett